Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.

Mehta SD, Maclean I, Ndinya-Achola JO, Moses S, Martin I, Ronald A, Agunda L, Murugu R, Bailey RC, Melendez J, Zenilman JM.

Antimicrob Agents Chemother. 2011 Aug;55(8):3882-8. doi: 10.1128/AAC.00155-11. Epub 2011 May 23.

2.

Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.

Lee H, Hong SG, Soe Y, Yong D, Jeong SH, Lee K, Chong Y.

Sex Transm Dis. 2011 Nov;38(11):1082-6. doi: 10.1097/OLQ.0b013e31822e60a4.

PMID:
21992988
3.

Cephalosporin and azithromycin susceptibility in Neisseria gonorrhoeae isolates by site of infection, British Columbia, 2006 to 2011.

Hottes TS, Lester RT, Hoang LM, McKay R, Imperial M, Gilbert M, Patrick D, Wong T, Martin I, Ogilvie G.

Sex Transm Dis. 2013 Jan;40(1):46-51. doi: 10.1097/OLQ.0b013e31827bd64c.

PMID:
23250301
4.

High prevalence of mutations in quinolone-resistance-determining regions and mtrR loci in polyclonal Neisseria gonorrhoeae isolates at a tertiary hospital in Southern Taiwan.

Chen PL, Lee HC, Yan JJ, Hsieh YH, Lee NY, Ko NY, Lin CW, Chang CM, Wu CJ, Lee CC, Ko WC.

J Formos Med Assoc. 2010 Feb;109(2):120-7. doi: 10.1016/S0929-6646(10)60032-0.

5.

Retrospective analysis of antimicrobial susceptibility trends (2000-2009) in Neisseria gonorrhoeae isolates from countries in Latin America and the Caribbean shows evolving resistance to ciprofloxacin, azithromycin and decreased susceptibility to ceftriaxone.

Starnino S; GASP-LAC Working Group, Galarza P, Carvallo ME, Benzaken AS, Ballesteros AM, Cruz OM, Hernandez AL, Carbajal JL, Borthagaray G, Payares D, Dillon JA.

Sex Transm Dis. 2012 Oct;39(10):813-21.

PMID:
23001269
7.

Antimicrobial susceptibility and molecular determinants of quinolone resistance in Neisseria gonorrhoeae isolates from Shanghai.

Yang Y, Liao M, Gu WM, Bell K, Wu L, Eng NF, Zhang CG, Chen Y, Jolly AM, Dillon JA.

J Antimicrob Chemother. 2006 Oct;58(4):868-72. Epub 2006 Jul 30.

8.

Trends in antimicrobial resistance in Neisseria gonorrhoeae isolated in Canada: 2000-2009.

Martin I, Jayaraman G, Wong T, Liu G, Gilmour M; Canadian Public Health Laboratory Network.

Sex Transm Dis. 2011 Oct;38(10):892-8. doi: 10.1097/OLQ.0b013e31822c664f.

PMID:
21934558
9.

Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.

Tanaka M, Nakayama H, Huruya K, Konomi I, Irie S, Kanayama A, Saika T, Kobayashi I.

Int J Antimicrob Agents. 2006 Jan;27(1):20-6. Epub 2005 Nov 28.

PMID:
16318912
10.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.

Dillon JA, Li H, Sealy J, Ruben M, Prabhakar P; Caribbean GASP Network. Gonococcal Antimicrobial Surveillance Program.

Sex Transm Dis. 2001 Sep;28(9):508-14.

PMID:
11518867
11.

Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.

Gose S, Nguyen D, Lowenberg D, Samuel M, Bauer H, Pandori M.

BMC Infect Dis. 2013 Dec 4;13:570. doi: 10.1186/1471-2334-13-570.

13.

Molecular characterization of quinolone-resistant Neisseria gonorrhoeae isolates from Brazil.

Uehara AA, Amorin EL, Ferreira Mde F, Andrade CF, Clementino MB, de Filippis I, Neves FP, Pinto Tde C, Teixeira LM, Giambiagi-Demarval M, Fracalanzza SE.

J Clin Microbiol. 2011 Dec;49(12):4208-12. doi: 10.1128/JCM.01175-11. Epub 2011 Oct 5.

14.

Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.

Kovari H, de Melo Oliveira MD, Hauser P, Läuchli S, Meyer J, Weber R, Zbinden R.

BMC Infect Dis. 2013 Dec 26;13:603. doi: 10.1186/1471-2334-13-603.

15.
16.

Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.

Endimiani A, Guilarte YN, Tinguely R, Hirzberger L, Selvini S, Lupo A, Hauser C, Furrer H.

BMC Infect Dis. 2014 Feb 25;14:106. doi: 10.1186/1471-2334-14-106.

17.

Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure.

Lewis DA, Sriruttan C, Müller EE, Golparian D, Gumede L, Fick D, de Wet J, Maseko V, Coetzee J, Unemo M.

J Antimicrob Chemother. 2013 Jun;68(6):1267-70. doi: 10.1093/jac/dkt034. Epub 2013 Feb 14.

18.

Strain typing and antimicrobial resistance of fluoroquinolone-resistant Neisseria gonorrhoeae causing a California infection outbreak.

Morris SR, Moore DF, Hannah PB, Wang SA, Wolfe J, Trees DL, Bolan G, Bauer HM.

J Clin Microbiol. 2009 Sep;47(9):2944-9. doi: 10.1128/JCM.01001-09. Epub 2009 Jul 22.

19.

Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.

Mlynarczyk-Bonikowska B, Serwin AB, Golparian D, Walter de Walthoffen S, Majewski S, Koper M, Malejczyk M, Domeika M, Unemo M.

BMC Infect Dis. 2014 Feb 6;14:65. doi: 10.1186/1471-2334-14-65.

20.

Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain.

Cámara J, Serra J, Ayats J, Bastida T, Carnicer-Pont D, Andreu A, Ardanuy C.

J Antimicrob Chemother. 2012 Aug;67(8):1858-60. doi: 10.1093/jac/dks162. Epub 2012 May 7.

Items per page

Supplemental Content

Write to the Help Desk